Alec K. Simon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alec K. Simon has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Amanda Zwick
University of Florida
1 shared publicationAshley E. Holland
University of Florida
1 shared publicationAshley Ross
University of Florida
1 shared publication- Elisa Janine Gonzalez-Rothi
Department of Physical Therapy, University of Florida, Gainesville, Florida, United States
1 shared publication Gordon S. Mitchell
University of Florida - Department of Physical Therapy
1 shared publication- Juliet Victoria Santiago
Department of Neurology, Emory University, Atlanta, Georgia, USA; Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Intermittent Hypoxia Differentially Regulates Adenosine Receptor Expression in Phrenic Motor Neurons with and Without Cervical Spinal Cord Injury
Cervical spinal cord injury (cSCI) impairs neural drive to the respiratory muscles, causing life- threatening complications such as respiratory insufficiency and diminished airway protection. Repetitive 'low dose' acute intermittent hypoxia (AIH) is a promising strategy to restore motor function in people with chronic SCI. Conversely, 'high dose' chronic intermittent hypoxia (CIH; ~8 hours/night), such as experienced during sleep apnea, causes pathology. Sleep apnea, spinal ischemia, hypoxia and neuroinflammation associated with cSCI increase extracellular adenosine concentrations and activate spinal adenosine receptors which in turn constrains the functional benefits of therapeutic AIH (tAIH). Adenosine 1 and 2A receptors (A1, A2A) compete to determine net cAMP signaling and likely the tAIH efficacy with chronic cSCI. Since cSCI and intermittent hypoxia may regulate adenosine receptor expression in phrenic motor neurons, we tested the hypotheses that: 1) daily AIH (28 days) downregulates A2A and upregulates A1 receptor expression; 2) CIH (28 days) upregulates A2A and downregulates A1 receptor expression; and 3) cSCI alters the impact of CIH on adenosine receptor expression. Daily AIH had no effect on either adenosine receptor in intact or injured rats. However, CIH exerted complex effects depending on injury status. Whereas CIH increased A1 receptor expression in intact (not injured) rats, it increased A2A receptor expression in spinally injured (not intact) rats. The differential impact of CIH reinforces the concept that the injured spinal cord behaves in distinct ways from intact spinal cords, and that these differences should be considered in the design of experiments and/or new treatments for chronic cSCI. Funding Information: This work was supported by the National Institutes of Health (HL147554, HL148030 & OT2OD023854) and the University of Florida McKnight Brain Institute. Additional support was provided to Y.B. Seven (R21 NS119862), L.L. Allen (T32 HD043730) and E.J. Gonzalez-Rothi (K12 HD055929, DOD SCI160123). A.E. Holland and J.V. Santiago were supported by the American Physiological Society (UGRSF, STRIDE). Conflict of Interests: The authors declare no competing financial interests. Ethical Approval: All experimental procedures were approved by the Animal Care and Use Committee at the University of Florida in accordance with the standards set forth by the National Institutes of Health Guide and Use of Laboratory Animals.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessIntermittent Hypoxia Differentially Regulates Adenosine Receptor Expression in Phrenic Motor Neurons with and Without Cervical Spinal Cord Injury
Cervical spinal cord injury (cSCI) impairs neural drive to the respiratory muscles, causing life- threatening complications such as respiratory insufficiency and diminished airway protection. Repetitive 'low dose' acute intermittent hypoxia (AIH) is a promising strategy to restore motor function in people with chronic SCI. Conversely, 'high dose' chronic intermittent hypoxia (CIH; ~8 hours/night), such as experienced during sleep apnea, causes pathology. Sleep apnea, spinal ischemia, hypoxia and neuroinflammation associated with cSCI increase extracellular adenosine concentrations and activate spinal adenosine receptors which in turn constrains the functional benefits of therapeutic AIH (tAIH). Adenosine 1 and 2A receptors (A1, A2A) compete to determine net cAMP signaling and likely the tAIH efficacy with chronic cSCI. Since cSCI and intermittent hypoxia may regulate adenosine receptor expression in phrenic motor neurons, we tested the hypotheses that: 1) daily AIH (28 days) downregulates A2A and upregulates A1 receptor expression; 2) CIH (28 days) upregulates A2A and downregulates A1 receptor expression; and 3) cSCI alters the impact of CIH on adenosine receptor expression. Daily AIH had no effect on either adenosine receptor in intact or injured rats. However, CIH exerted complex effects depending on injury status. Whereas CIH increased A1 receptor expression in intact (not injured) rats, it increased A2A receptor expression in spinally injured (not intact) rats. The differential impact of CIH reinforces the concept that the injured spinal cord behaves in distinct ways from intact spinal cords, and that these differences should be considered in the design of experiments and/or new treatments for chronic cSCI. Funding Information: This work was supported by the National Institutes of Health (HL147554, HL148030 & OT2OD023854) and the University of Florida McKnight Brain Institute. Additional support was provided to Y.B. Seven (R21 NS119862), L.L. Allen (T32 HD043730) and E.J. Gonzalez-Rothi (K12 HD055929, DOD SCI160123). A.E. Holland and J.V. Santiago were supported by the American Physiological Society (UGRSF, STRIDE). Conflict of Interests: The authors declare no competing financial interests. Ethical Approval: All experimental procedures were approved by the Animal Care and Use Committee at the University of Florida in accordance with the standards set forth by the National Institutes of Health Guide and Use of Laboratory Animals.